carteolol has been researched along with Migraine Disorders in 1 studies
Carteolol: A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.
Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shapiro, MK | 1 |
| Gorn, R | 1 |
1 other study available for carteolol and Migraine Disorders
| Article | Year |
|---|---|
The possible treatment of migraine with carteolol hydrochloride.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Carteolol; Female; Glaucoma; Humans; Middle Ag | 1999 |